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a b s t r a c t
We present a patient with asymptomatic apical hypertrophic cardiomyopathy (AHCM) who
recently developed cardiac arrhythmias, and shortly discuss the diagnostic modalities,
differential diagnosis, and treatment strategy for this condition. AHCM is a rare form of
hypertrophic cardiomyopathy, which usually involves the apex of the left ventricle. AHCM
can occurwith varied presentations such as chest pain, palpitations, dyspnea, syncope, atrial
ﬁbrillation, myocardial infarction, embolic events, ventricular ﬁbrillation, and congestive
heart failure. The most peculiar electrocardiogram ﬁndings are giant T-waves inversion in
the precordial leads with left ventricular (LV) hypertrophy. A transthoracic echocardiogram
is the initial diagnosticmodality in the evaluation of AHCM and shows hypertrophy of the LV
apex. Other diagnostic modalities, including left ventriculography, multislice spiral comput-
ed tomography, and cardiac magnetic resonance imagings, are also valuable tools. Medica-
tions used to manage include verapamil, beta-blockers, and antiarrhythmic agents. An
implantable cardioverter deﬁbrillator (ICD) is recommended for high-risk patients.
# 2015 Cardiological Society of India. Published by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. IntroductionApical hypertrophic cardiomyopathy (AHCM) is an uncommon
type of hypertrophic cardiomyopathy (HCM), which usually
involves the left ventricle apex and rarely involves the right
ventricular apex or both.1 Initially, it was thought that AHCM is
limited only to the Japanese population, but nowadays it is
also found in other populations.* Corresponding author.
E-mail address: drhemant.chaturvedi@gmail.com (H. Chaturvedi).
http://dx.doi.org/10.1016/j.ihj.2015.08.011
0019-4832/# 2015 Cardiological Society of India. Published by Elsevier
(http://creativecommons.org/licenses/by-nc-nd/4.0/).2. Case reportA 77-year-old Indian male with a history of hypertension and
diabetes mellitus was asymptomatic before July 2014. He had
complaints of two episodes of syncope in the last 1 month.
There was no family history of sudden death, congestive heart
failure, or cardiomyopathy. On examination, his blood
pressure was 118/72 mmHg and heart rate 67 bpm (beats perB.V. This is an open access article under the CC BY-NC-ND license
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heart failure. The rest of the examination was normal. A 12-
lead electrocardiogram (ECG) showed right bundle branch
block (RBBB) with generalized giant T wave inversion with
frequent ventricular premature complexes (VPCs)/ventricular
bigeminy (Fig. 1). The cardiac enzymes and chest X-ray
were normal. Initial transthoracic echocardiogram (TTE)
was reported as moderate concentric left ventricular (LV)
hypertrophy (Inter ventricular septum thickness 1.39 cm) with
[(Fig._1)TD$FIG]
Fig. 1 – Resting 12 lead electrocardiogram showing RBBB withMild Aortic Regurgitation and normal LV systolic function
LVEF (Left ventricular ejection fraction) 60%. Holtermonitoring
was done, which recorded frequent unifocal VPCs with
episodes of ventricular runs (Maximum one lasted for 16 s)
having all negative QRS concordance morphology (Fig. 2),
which were managed with antiarrhythmic medication (Amia-
darone).
He was then referred to higher institute for electrophysio-
logical study and Radio frequency ablation, where he hadgeneralized T wave inversion and ventricular bigeminy.
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Fig. 2 – Holter strip showing ventricular run.
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cardia) with intermittent bradycardia (Heart rate 37 bpm) with
blood pressure of 100/70 mmHg. He underwent Temporary
pacemaker implantation in view of recurrent VT (Ventricular[(Fig._3)TD$FIG]
Fig. 3 – Transthoracic echocardiogram showed apical
hypertrophy of left ventricle; lateral wall hypertrophy more
than apical septum; Classical ‘‘ace of spades sign’’tachycardia) and underlying bradycardia. Thereafter, he was
managed with antiarrhythmic (amiadarone infusion).
In view of underlying cardiac disease with recurrent VT
(Ventricular tachycardia), an inﬁltrative disorder was sus-
pected and CECT (Contrast enhanced Computerized tomogra-
phy) chest was done, which did not reveal any signiﬁcant
ﬁndings.
He underwent Coronary angiography, which revealed
single vessel disease (Non dominant Right Coronary Artery
100% mid occlusion) that did not explain the arrhythmia and
syncopal episodes. Left ventriculography was done as a
routine, which suggested gross apical hypertrophy.
Then again, meticulous transthoracic echocardiogram (TTE)
was done which showed Apical hypertrophy of left ventricle;
lateral wall hypertrophy more than apical septum (Apical IVS
thickness 1.33 cm, Apex thickness 1.24 cm, Apical lateral wall
thickness 1.98 cm, posterior wall thickness 1.18 cm) (Fig. 3
Classical ‘‘ace of spades sign’’) typically of AHCM with
thickened sclerotic Aortic valve, Mild AR, Normal LV systolic
function; LVEF 60%. Lateral wall thickening was smooth,
homogenous, and non-trabeculated (to differentiate with
possibility of Non-compacted LV cardiomyopathy) and no
wall motion abnormality was detected (to differentiate
with possibility of LV clot). He was shifted for cardiac
magnetic resonance imaging (MRI) but it could not be done
due to hemodynamical instability and poor co-operation of
patient.
He then underwent dual chamber implantable cardioverter
deﬁbrillator (ICD) implantation for prevention of fatal ventricu-
lar arrhythmias. Thereafter, the patient is clinically and
hemodynamically stable. On follow-up visits, his family was
screened for familial association, which was negative.
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dominant inheritance.3 A mutation in sarcoma gene (E101K
mutation in the alpha-cardiac actin gene) has been found in
such families. AHCM is not common in compare of patients
with asymmetric septal hypertrophy. Of all the HCM patients
in Japan, the prevalence of AHCM was 15%, whereas in USA,
the prevalence was only 3%.2 AHCM has been divided into
three types as per morphology: pure focal, pure diffuse, and
mixed, all of which pure focal is most common type.4 It can be
divided into two groups based on whether they had isolated
asymmetric apical hypertrophy (pure AHCM) or with co-
existent hypertrophy of the interventricular septum (mixed
AHCM).5 The diagnostic parameters for AHCM included
presence of asymmetric LV hypertrophy, conﬁned mainly to
the LV apex, with an apical wall thickness ≥15 mm and a ratio
of maximal apical to posterior wall thickness ≥1.5 mm, on the
basis of trans thoracic echocardiogram or MRI.5
About 54% of patients with AHCM are symptomatic and the
most common symptoms that patients present with are chest
pain, followed by palpitations, dyspnea, and syncope.5 AHCM
may also manifest as myocardial infarction, embolic events,
atrial ﬁbrillation, ventricular ﬁbrillation, and congestive heart
failure.5 Physical signs of an audible/palpable fourth heart
sound (S4) and a new onsetmurmur are common.5 Our patient
was with no family history and had no physical ﬁndings.
The most common ECG ﬁndings are negative T-waves in
the precordial leads, which were seen in 93% of patients,
followed by LV hypertrophy in 65% of patients.5 The ECG in our
patient showed RBBB with generalized T wave inversion
(>7 mm deep) and ventricular bigeminy. A contrast echocar-
diogram is useful in establishing the diagnosis when the
baseline images are suboptimal.6 Multislice spiral computed
tomography can also be useful to diagnose AHCM; apart from
diagnosis it provides other information like cardiac anatomy,
function, and coronary arteries.7 When diagnosing the
patients with inconclusive echocardiography is the problem,
then Cardiac MRI is also a valuable tool.8 Although transtho-
racic echocardiography is the most common initial diagnostic
test for AHCM, still cardiac MRI is the best diagnostic tool to
diagnose AHCM.
AHCM may simulate other conditions, including apical
cardiac tumors,9 LV apical thrombus,10 isolated ventricular
non-compaction,11 endomyocardial ﬁbrosis (EMF),12 and coro-
nary artery disease.13 Patients with AHCM having chest pain
can be mistaken for ischemia from coronary artery disease.13
Mostly these patients undergo a nuclear scan or coronary
angiography for abnormal ECG.15 Most of the patients with
AHCMwithmyocardial infarction have an apical infarct and in
these patients echocardiography imaging showed that wall
motion abnormalities vary from apical aneurysm to apical
hyopokinesis.5 Some patients may have asymptomatic apical
infarction.5
Cardiac MRI differentiates Isolated ventricular non-com-
paction from AHCM by high resolution images.11 Contrast
echocardiogram can be used to differentiate AHCM from a LV
apical mass (thrombus or tumor).10 Verapamil, beta-blockers,
and antiarrhythmic agents are used in symptomatic patientswith AHCM.5 Verapamil and beta-blockers are proved to be
beneﬁcial in ameliorates the symptoms in AHCM patients.14,16
Amiodarone is used in the treatment of atrial ﬁbrillation and
ventricular arrhythmias.17 ICD has been used in AHCM
patients with cardiac arrest or frequent non-sustained
ventricular tachycardia on holter monitoring.18
The prognosis of AHCM is usually benign. AHCM patients
had overall mortality rate of 10.5% and mortality due to
cardiovascular disease was 1.9% after a follow-up of 13.6  8.3
years.5 Patients with asymmetric septal hypertrophy have
more common sudden death and cardiovascular events than
in those with AHCM.19
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